Gainesville, FL10 Active Studies

Type 1 Diabetes Clinical Trials in Gainesville, FL

Find 10 actively recruiting type 1 diabetes clinical trials in Gainesville, FL. Connect with local research sites and explore new treatment options.

10
Active Trials
8
Sponsors
4,316
Enrolling

Recruiting Type 1 Diabetes Studies in Gainesville

NCT05899439Recruiting

Immune Function and the Progression to T1D

To elucidate the mechanisms by which type 1 diabetes-associated genes; IFIH1, TYK2, IKZF4, as well as total genetic risk, impart functional immunoregulatory abnormalities that result in expansion of s...

Gainesville, FL2,800 participantsUniversity of Florida
View Study Details
NCT07088068Recruiting

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

This is a multicenter, randomized, double-blind, parallel, placebo-controlled Phase 3, 2-arm study for treatment. The purpose of this study is to measure change in glycemic control and prandial insul...

Gainesville, FL723 participantsSanofi
View Study Details
NCT06481904Recruiting

Registry for Stage 2 Type 1 Diabetes

Stage 2 Type 1 Diabates (T1D) is an early stage of T1D characterized by dysglycemia but not yet leading to clinical symptoms. Progression of the disease to Stage 3 (clinical T1D), leads to overt hyper...

Gainesville, FL200 participantsSanofi
View Study Details
NCT07187531Recruiting

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

This is a Phase 2b, investigator- and participant-blinded, placebo-controlled, parallel-arm study to evaluate the efficacy, safety and tolerability of SAB 142 in patients with Stage 3 New Onset of Typ...

Gainesville, FL159 participantsSAb Biotherapeutics, Inc.
View Study Details
NCT07061574Recruiting

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

This multi-center randomized controlled trial will assess the safety and efficacy of ATG followed by either adalimumab or verapamil in preserving insulin secretion 2 years from randomization in person...

Gainesville, FL120 participantsCity of Hope Medical Center
View Study Details
NCT07224321Recruiting

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

INHALE-1st is a Phase 2, single-arm, multi-center, clinical study evaluating the safety and efficacy of Afrezza in combination with subcutaneously-injected basal insulin (BI) for youth 10 to \<18 year...

Gainesville, FL100 participantsMannkind Corporation
View Study Details
NCT06783309Recruiting

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending doses of CNP-103. The approximately 208-da...

Gainesville, FL72 participantsCOUR Pharmaceutical Development Company, Inc.
View Study Details
NCT07142252Recruiting

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

This Phase 2 study is a 2-arm, multi-center, double-masked (masking of the participant, care provider and investigator), placebo-controlled, 2:1 randomized trial design in new onset T1D participants (...

Gainesville, FL66 participantsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
View Study Details
NCT06455319Recruiting

Precision Administration of Anti-thymocyte Globulin With or Without Verapamil

T cell directed therapy, anti-thymocyte globulin (ATG), in low doses, has been shown to lower HbA1c and preserve endogenous insulin production (measured by C-peptide) in individuals with recently diag...

Gainesville, FL60 participantsUniversity of Florida
View Study Details
NCT06919354Recruiting

A Study of GNTI-122 in Adults Recently Diagnosed With T1D

This is a 78-week single arm, multi-center, Phase 1 study to evaluate the safety, tolerability, cellular kinetics, and biomarker changes in C-peptide over time of GNTI-122, an investigational cell the...

Gainesville, FL16 participantsGentiBio, Inc
View Study Details

About Type 1 Diabetes Clinical Trials in Gainesville

Type 1 diabetes is an autoimmune condition where the immune system destroys insulin-producing beta cells in the pancreas. It typically develops in childhood or young adulthood and requires lifelong insulin therapy. Research is exploring artificial pancreas systems, immunotherapy, and beta cell replacement.

There are currently 10 type 1 diabetes clinical trials recruiting participants in Gainesville, FL. These studies are seeking a combined 4,316 participants. Research is being sponsored by University of Florida, Sanofi, SAb Biotherapeutics, Inc. and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Type 1 Diabetes Clinical Trials in Gainesville — FAQ

Are there type 1 diabetes clinical trials in Gainesville?

Yes, there are 10 type 1 diabetes clinical trials currently recruiting in Gainesville, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Gainesville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Gainesville research site will contact you about next steps.

Are clinical trials in Gainesville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Gainesville studies also compensate for your time and travel.

What type 1 diabetes treatments are being tested?

The 10 active trials in Gainesville are testing new therapies including novel drugs, biologics, and treatment approaches for type 1 diabetes.

Data updated July 13, 2026 from ClinicalTrials.gov